SAROJA PHARMA INDUS IND L Financial Ratios
SAROJA · Chemicals · Current price ₹40.95
P/E ratio
10.2x
P/B ratio
1.0x
ROE
6.6%
ROCE
11.3%
Debt / Equity
0.83
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 10.2x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 6.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 11.3% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.83 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with SAROJA PHARMA INDUS IND L's latest numbers.
SAROJA PHARMA INDUS IND L profitability
SAROJA PHARMA INDUS IND L generates a return on equity of 6.6% and a return on capital employed of 11.3%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.83 and a P/E of 10.2x, SAROJA PHARMA INDUS IND L is moderately leveraged. Our overall business-quality score for the company is 4.0 / 10.
Understand the ratios
More on SAROJA PHARMA INDUS IND L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.